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The production of adenosine triphosphate (ATP) in mitochondria, requires the oxidation of 
energy rich compounds to generate a proton motive force (pmf), a chemical potential difference 
for protons, across the inner membrane. This pmf powers the ATP synthase, a molecular 
machine with a rotary action, to synthesize ATP. The assembly of human ATP synthase from 
twenty-seven nuclear encoded proteins and two mitochondrially encoded subunits in the inner 
organellar membrane involves the formation of intermediate modules representing the F1-
catalytic domain, the peripheral stalk and associated membrane subunits, and the c8-ring in the 
membrane part of the rotor. Here, we describe how components of the peripheral stalk and 
three associated membrane subunits are assembled and introduced into the enzyme complex. 
(118 words) 
Abstract  
The ATP synthase in human mitochondria is a membrane bound assembly of 29 proteins of 18 
kinds organized into F1-catalytic, peripheral stalk (PS) and c8-rotor ring modules. All but two 
membrane components are encoded in nuclear genes, synthesized on cytoplasmic ribosomes, 
imported into the mitochondrial matrix, and assembled into the complex with the mitochondrial 
gene products, ATP6 and ATP8. Intermediate vestigial ATPase complexes formed by 
disruption of nuclear genes for individual subunits provide a description of how the various 
domains are introduced into the enzyme. From this approach, it is evident that three alternative 
pathways operate to introduce the PS module (including associated membrane subunits e, f and 
g). In one pathway, the PS is built up by addition to the core subunit b of membrane subunits 
e and g together, followed by membrane subunit f. Then this b-e-g-f complex is bound to the 
preformed F1-c8 module by subunits OSCP and F6. The final component of the PS, subunit d, 
is added subsequently to form a key intermediate that accepts the two mitochondrially encoded 
subunits. In another route to this key intermediate, first e and g together and then f are added 
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to a pre-formed F1-c8-OSCP-F6-b-d complex. A third route involves the addition of the c8-ring 
module to the complete F1-PS complex. The key intermediate then accepts the two 
mitochondrially encoded subunits, stabilized by the addition of subunit j, leading to an ATP 
synthase complex that is coupled to the proton motive force and capable of making ATP. [248 
words] 
Introduction 
Energy derived from oxidative metabolism generates a proton-motive force (pmf) across the 
inner membranes of mitochondria, which the ATP synthase harnesses to provide most cellular 
ATP from ADP and phosphate by a rotary catalytic mechanism (1–3). Human ATP synthase 
is closely related in subunit composition and sequences to the bovine enzyme (3). Bovine ATP 
synthase is a protein-lipid complex made from 29 protein subunits of 18 types, including a 
regulatory protein, IF1 contributing a mass of 591 kDa, and five specifically bound 
phospholipids (Fig. 1 and SI Appendix Fig. S1) (3, 4). The protein subunits of the human 
enzyme are organized by an assembly process into membrane extrinsic and membrane intrinsic 
domains, linked by a central stalk and a peripheral stalk (PS) (5, 6). The PS is often taken to 
denote the membrane extrinsic region of the stator. Here, because of the way this region of the 
enzyme is assembled, the term PS signifies the membrane extrinsic region of the peripheral 
stalk plus the membrane intrinsic region of subunits b, and the associated supernumerary 
subunits e, f and g. Two additional subunits, known previously as 6.8PL (6.8 kDa proteolipid) 
and DAPIT (diabetes associated protein in insulin sensitive tissue) are referred to here 
according to the names of their yeast orthologs, subunits j and k, respectively (4, 5, 7–10). 
Fifteen of the seventeen kinds of subunits of human ATP synthase are nuclear gene products 
that are imported into the organelle, where they are assembled together to form the complete 
complex with the two remaining subunits ATP6 (or a) and ATP8 (or A6L), which are both 
encoded in mitochondrial DNA and synthesized in the mitochondrial matrix (11). Currently, it 
 4 
is not known when the five phospholipids are incorporated into the complex (see Fig. S1). 
Previously, we have described the later stages of the assembly of nuclear encoded subunits of 
the membrane domain based upon editing specific human genes with CRISPR-Cas9, and by 
characterizing the partial vestigial ATP synthase complexes that assemble in these cells, and 
also by the study of the assembly process in ρ0 cells, which lack mitochondrial DNA, and 
therefore are incapable of making subunits ATP6 and ATP8 (5, 12). From these studies an F1-
PS-c8-ring complex has been identified as a fundamental assembly intermediate, that provides 
the template for insertion of the two mitochondrially encoded subunits ATP6 and ATP8 in an 
unknown order. Their insertion is completed by the addition of subunit j which augments the 
entry of ATP6, evidently by holding it in close juxtaposition to the c8-ring as required for the 
formation of the trans-membrane proton pathway at the c8-ring:ATP6 interface. On the basis 
of the structures of the monomer:monomer interface in the dimeric bovine and yeast ATP 
synthases (4, 13), the entry of subunit j also allows the monomeric complexes to associate into 
the dimeric complexes found along the edges of the cristae in mitochondria (14–17). The final 
subunit to be added, subunit k, may be involved, in tethering dimers into tetramers and higher 
oligomers (5, 18). Here, we describe routes for assembly and incorporation of the PS module 
into the complex. 
Results 
Human Cells Lacking Subunits d and F6. ATP5PD and ATP5PF encoding, respectively, 
subunits d and F6 of ATP synthase (SI Appendix, Fig. S2) were disrupted in HAP1-WT (wild-
type) cells by CRISPR-Cas9 (SI Appendix, Tables S1 and S2, and Fig. S3). The resulting clonal 
cells, HAP1-Δd and HAP1-ΔF6, lacked the edited subunits, and produced different vestigial 
complexes with PS subunits depleted or absent (Fig. 2, SI Appendix, Fig. S4). The removal of 
either subunit d or F6 had little effect on the initial rate of cell proliferation, but after about 60-
70 h, growth ceased and the confluence declined (SI Appendix, Fig. S5), probably because of 
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increased glycolysis and faster acidification of the culture medium in mutant cells than in WT 
cells under non-inhibited conditions (SI Appendix, Fig. S5). The deletion of subunit d or F6 
affected respiration severely (SI Appendix, Fig. S5), similar to the impact of individual removal 
of the OSCP or subunits b, c, e, f and g (5, 12, 19). The lack of effect of oligomycin on these 
cells indicated that any intermediate vestigial ATP synthases are uncoupled from pmf. The 
levels of complexes I, III, and IV, but not complex II, were lower in both mutant cells (SI 
Appendix, Fig. S6), with an associated lower respiratory capacity (SI Appendix, Fig. S5). The 
effect of removing the PS subunit F6 had a greater impact on assembly (Fig. 2), and the vestigial 
complex in HAP1-ΔF6 cells contained significant levels of only the five subunits from the F1 
domain and the membrane subunit c (Fig. 3A; SI Appendix, Fig. S7A and Datasets S1 and S2), 
consistent with the presence of a F1-c8 subcomplex, observed previously when either of two 
other PS constituent subunits, b or OSCP, was removed (19). The quantitative MS analysis 
(Fig. 3A) showed that the level of the vestigial F1-c8 complex in HAP1-ΔF6 cells was reduced 
to ca. 50% of the level of intact ATP synthase in HAP1-WT cells. Similarly, in HAP1-Δd cells, 
the constituent subunits of the F1-c8 component were present at ca. 60-65% of the levels in WT 
cells, with the remaining PS and membrane subunits at ca. 30-40% of their WT abundances 
(Fig. 3B; SI Appendix, Fig. S7B and Datasets S3 and S4). Therefore, it appears that HAP1-Δd 
cells assemble both an F1-c8 subcomplex, and F1-c8 associated with a PS complex containing 
subunits OSCP, b, F6, e, f and g. An alternative interpretation is that the F1-c8-OSCP-F6-b-e-f-
g vestigial complex in HAP1-Δd cells is somewhat unstable and dissociates partially during 
purification. The formation of the vestigial complexes in both derivative cells was 
accompanied by an elevation in the relative level of IF1-M1, and a decrease in IF1-M3 (Figs. 
3A and 3B).  
The quantitative relative levels of subunits in mitoplasts showed that removal of subunit 
d was accompanied by a substantial reduction in the levels of mitochondrially encoded ATP 
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synthase subunits ATP6 and ATP8, and the level of subunit j was reduced also (Figs. 3D, SI 
Appendix, Fig. S8A and Datasets S5 and S6). None of these three subunits is a component of 
the vestigial complex in HAP1-Δd cells. The low levels of ATP6, ATP8 and subunit j in 
mitoplasts may reflect a rapid turnover of unassembled subunits, or down-regulation of their 
expression in the absence of an assembled enzyme. A comparison of the relative levels of the 
other subunits in mitoplasts indicates a small excess of F1-c8 components, supporting the 
presence of both F1-c8 and F1-c8 associated with a PS complex containing subunits OSCP, b, 
F6, e, f and g. The deletion of subunit F6 was accompanied by a large decrease in the levels of 
subunits ATP6, ATP8 and d, and also low levels of b, OSCP, e, f, g and j, consistent with these 
cells forming predominantly a F1-c8 vestigial complex (Figs. 3C, SI Appendix, Fig. S8B and 
Datasets S7 and S8). In both mutant cells, the difference in the relative levels of subunit k in 
mitoplasts compared with the purified complexes was larger than for other ATP synthase 
subunits, indicating the presence of the free unassociated subunit. 
Oligomeric State of Vestigial ATP Synthases. Analysis by both BN- and CN-PAGE of the 
vestigial ATP synthase from HAP1-ΔF6 cells demonstrated the presence of a single dominant 
band, cross-reacting with an antibody for the α-subunit, at a position corresponding to a 
monomeric F1-c8 subcomplex of ATP synthase (s1 in Fig. 4), supporting the quantitative 
analysis (Fig. 3A). A minor component at ca.160 kDa detected in CN-PAGE analysis contained 
at least the PS subunit b and supernumerary subunits e, f and g (s2 in Fig. 4B), and a similar 
complex was detected in wild type cells. This b-e-g-f containing subcomplex was prominent 
in analyses by both BN- and CN-PAGE of samples from HAP1-Δd cells. These latter samples 
also contained the F1-c8 subcomplex (s1), and additional bands detected in BN-PAGE gels 
could be monomeric (m) and dimeric (d) forms of a vestigial F1-c8-OSCP-F6-b-e-f-g complex 
(Fig. 4A). As subunit j, the key dimerising component (4) is largely absent, the presence of 
dimers can be explained either by the face-to-back association of monomers via subunit g, or 
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by monomeric complexes linked, as in the structure of tetrameric porcine ATP synthase (20), 
by dimeric IF1(21, 22). The IF1-M1 form is consistently found at increased relative levels in 
the vestigial complexes (Fig. 3) (5, 12, 19). The quantitative mass spectrometric analyses 
suggested that HAP1-Δd cells produce both an F1-c8 and F1-c8-OSCP-F6-b-e-f-g vestigial 
complex. The low intensity of the apparent monomeric and dimeric F1-c8-OSCP-F6-b-e-f-g 
vestigial complexes, combined with the strong b-e-f-g band suggests that the F1-c8-OSCP-F6-
b-e-f-g vestigial complex may be unstable and give rise to the combination of complexes 
observed in the native gel analyses of samples from HAP1-Δd cells. 
The b-e-g and b-e-g-f Subcomplexes of ATP Synthase. The formation of a b-e-g-f 
subcomplex in HAP1 cells was examined further in cell lines lacking individual subunits b, e, 
f, g and δ. It was demonstrated that the HAP1-Δe, -Δg and -Δf cells all form monomeric 
vestigial complexes containing the b-subunit, slightly smaller than intact monomeric ATP 
synthase, and that the complex formed by HAP1-Δf cells also contains subunits e and g (Fig. 
5), as observed before by BN-PAGE (5). Also, HAP1-Δf cells produced a smaller b-e-g 
subcomplex of ca. 150 kDa and this subcomplex was not formed when any one of subunits b, 
e or g was deleted. A monomeric vestigial complex of ca.700 kDa was not observed in HAP1-
Δδ cells, but they have a subcomplex of ca.160 kDa, containing subunits b, e, g and f, slightly 
larger than the b-e-g subcomplex as expected, and consistent with the assembly of a b-e-g-f 
subcomplex. The HAP1-Δδ cells also formed an uncharacterized 80 kDa complex containing 
subunit e. 
 Further evidence for the b-e-g-f complex was provided by the expression in HEK293-
Δδ cells of the b-subunit with a C-terminal Flag-Strep II tag, and analysis of the purified 
complex of the tagged subunit and associated proteins by gel and mass spectrometric analyses. 
The HEK293-Δδ cell line was employed so as to favor the formation of the b-e-g-f subcomplex 
(SI Appendix, Fig. S9A), as in HAP1-Δδ cells (Fig. 5). The reciprocally labelled control sample 
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for this experiment was provided by HEK293-Δδ cells where a C-terminally tagged version of 
the subunit j (which is not part of the b-e-g-f complex) was expressed. There was no evidence 
for or against a specific complex containing subunit j in the HEK293-Δδ cells (Fig. 6), but, as 
the majority of the data points occupy the upper right quadrant, the choice of tagged subunit j 
as a control was sub-optimal. However, only subunits e, f and g were appreciably associated 
with the tagged b-subunit (Fig. 6), and therefore the experiment provides further evidence for 
the formation of the b-e-g-f intermediate. 
Discussion 
The bovine and human ATP synthases have the same subunit composition and the sequences 
of the subunits are highly conserved (3, 12, 23). Therefore, the structure of the bovine enzyme 
(Fig. 1) is an excellent surrogate for that of the human enzyme that can be employed in the 
interpretation of the pathway of assembly of the human complex. The structure illustrates that 
the protein components of the PS, the OSCP, b-, d-, F6-, e-, f- and g-subunits, plus the ATP6- 
and ATP8-subunits, and the associated supernumerary membrane subunits j and k, constitute 
the enzyme’s stator against which the rotor turns (4). The rotor consists of central stalk 
components, subunits γ, δ and ε, which is bound to a ring of eight c-subunits in the membrane 
domain (24). During catalysis, the PS prevents the dissociation of the α3β3-domain from the 
central stalk by clamping it in position from above via interactions between the N-terminal 
regions of α-subunits with the N-terminal domain of the OSCP. Also, it resists the rotational 
torque of the central stalk, preventing the α3β3-domain and the rest of the stator domain from 
following the direction of rotation. The structure of the PS is elongated and largely α-helical, 
and it illustrates the roles of its individual components. The N-terminal domain of the OSCP, 
attached to the F1-domain, is linked to its C-terminal domain via a flexible region that provides 
a universal joint to accommodate the side-to-side rocking of the F1-domain during catalysis. 
This C-terminal domain of the OSCP is bound to bH4, the C-terminal α-helix of subunit b. α-
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Helix bH4 is attached to α-helix bH3, which extends about 150 Å through the core of the PS 
to the surface of the IMM and then across the membrane. Other α-helices in the F6 and d-
subunits, and another extending up from the membrane domain of subunit ATP8, are bound 
parallel to bH3, helping to rigidify most of the PS, except for a hinge in bH3 close to the 
membrane’s surface that allows the PS to flex during catalysis. The membrane bound N-
terminal region of the b-subunit is folded into two further α-helices, bH1and bH2, and together 
with the transmembrane domain of bH3, they form the skeleton of a wedge-shaped structure, 
with bH1 sitting on top on the matrix side of the IMM and transmembrane α-helices bH2 and 
bH3 subtending an angle of ca. 45o (SI Appendix Fig. S1). The association of the two wedges 
in the dimeric enzyme places the central rotatory axes of the monomeric enzymes at an angle 
to each other. The supernumerary subunits e, f and g also contribute to the structure of the 
wedge. The single transmembrane α-helices of each of subunits e and g augment α-helix bH2, 
and the top of the wedge on the matrix side of the membrane is provided by four amphipathic 
α-helices two in each of the g- and f-subunits, which lie in the lipid head-group region of the 
membrane. Internal cavities in the wedge are occupied by five specifically bound lipids, three 
cardiolipins (CDL1-CDL3) and two other lipids tentatively modelled as phosphatidyl glycerols 
(LHG4 and LHG5). These five lipids probably enhance the stability of the wedge (4). 
 In earlier studies of the assembly of the membrane domain of human ATP synthase, 
sub-complex (D) in Fig. 7 was characterized as a key intermediate in the later stages of the 
assembly process (5). It provides the template for the introduction of subunits ATP6 and ATP8, 
both encoded in mitochondrial-DNA, allowing the proton channel to be formed and then 
stabilized by the subsequent addition of subunit j, producing a coupled active ATP synthase. 
In subcomplex (D), the PS is already fully assembled. In the current work, other vestigial 
complexes have been characterized from the mitochondria of human cells, where various 
subunits of ATP synthase have been removed individually. They demonstrate that the PS is not 
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introduced into intermediate (D) by a unique route, but that there are at least three alternative 
paths for doing so (Fig. 7). In one path, illustrated in Fig. 7 (A) and (B), a b-e-g complex binds 
subunit f to form a b-e-g-f subcomplex. When the association of this assembly with F1-c8 was 
prevented for example in HAP1-ΔF6 cells, then b-e-g-f did not accumulate (Fig. 4), presumably 
because it was degraded in the mitochondria. The b-e-g-f subcomplex is probably an authentic 
assembly intermediate as it forms in the absence of an assembled F1-domain (Fig. 6), but it 
cannot be completely excluded that it is also the product of the breakdown of an F1-c8-PS sub-
complex, for example, either metabolically or artefactually during extraction of the vestigial 
complex with detergent and subsequent gel analyses. For example, in HAP1-Δd cells (Fig. 4), 
the substantial amounts of b-e-g-f that were observed are likely to have arisen from partial 
dissociation of an unstable F1-c8-OSCP-F6-b-e-f-g vestigial complex. A b-e-g complex, that 
probably contained subunit f also, has been described before in HeLa cells where subunit d had 
been depleted (25). According to Fig. 7, the b-e-g-f subcomplex then associates with the F1-c8 
subcomplex in the presence of subunits OSCP and F6, resulting in the formation of the 
substoichiometric intermediate (C). In a final step, the assembly of the PS is completed by the 
introduction of subunit d. In a second path to intermediate (D) in Fig. 7E and 7F, an F1-c8 
subcomplex, already associated with a partial PS consisting of subunits OSCP, b, d and F6, 
binds an e-g subcomplex, and then intermediate (D) is made by the addition of subunit f. In a 
third path, the intermediate (D) is formed by first the association of an F1-domain with a fully 
assembled PS, and then completed by the addition of the c8-ring. A fourth, but related pathway 
of assembly of human ATP synthase has been proposed based on the mass spectrometric 
analysis of protein complexes fractionated by native gel electrophoresis (26). Here, a b-e-g-f 
subcomplex becomes incorporated into a PS complex plus subunits ATP6, ATP8, j and k, 
which then associates with an F1-c8 sub-complex to produce the intact ATP synthase. From 
current knowledge, it is not possible to say which route, if any, is dominant, and under what 
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circumstances the alternative routes operate. In S. cerevisiae, subunit c, as well as ATP6 and 
ATP8, is encoded in the organellar genome. Here, an F1-PS-ATP6-ATP8 subcomplex forms 
first and then the c10-ring is incorporated (6). However, the formation of the intermediate 
subcomplex requires the participation of assembly factors Atp10, Atp23 and INAC (27). So 
far, no assembly factor has been found to be required for the assembly of the human PS (Fig. 
6, SI Appendix, Fig. S7), although others are needed to assist in the assembly of the F1-domain 
(28, 29), and creating the c8-ring and/or its association with the F1-domain (30). 
 The formation of a b-e-g complex followed by the addition of subunit f to make the b-
e-g-f subcomplex is consistent with the structure of the wedge domain (4), since subunit f is 
bound partially to the external surface of subunit g (SI Appendix, Fig. S1). From consideration 
of the structure, it seems likely that phospholipids CDL2, LHG4, CDL3 and LHG5 will be 
added to the b-e-g complex (effectively a nascent wedge complex) at as yet unspecified points 
before the addition of subunit f, and that CDL1 will be added subsequently (SI Appendix, Fig. 
S1). The incorporation of these lipids into the wedge domain of the ATP synthase is part of the 
assembly process of the enzyme and it warrants further investigation. Another issue requiring 
clarification is at what stage of the assembly process do the monomeric complexes dimerize? 
Two types of dimer can form, made from either appropriate vestigial complexes or from the 
fully assembled monomeric complex. They are the classic front-to-back dimers held together 
by interactions between j-subunits (4) with the rotatory axes at a range of acute angles, and 
those arising by the association of two monomers (partially or fully assembled) across what 
will become the dimer-dimer interface in the rows of dimers observed in the cristae. The latter 
class could arise from interactions between k-subunits in each monomer (5), or they could be 
held together by dimeric IF1 molecules bridging between the two catalytic F1-domains (20, 21). 
Low levels of dimeric forms of vestigial ATP synthase complexes lacking subunit j have been 
observed in ρ0, Δd and Δf cells (Fig. 4) (5, 12, 31), suggesting that they may be side-by-side 
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dimers. Conditions are known for extracting and purifying dimeric bovine complexes that have 
been verified by electron cryo-microscopy to be front-to-back dimers (4). Dimeric complexes 
are frequently observed in native gel analyses of extracts of mitochondrial membranes from 
wild-type and mutant cells, and are often assumed to be the classic type. However, the exact 
nature of the dimer cannot be ascertained with certainty without corroborative investigations, 
and improved protocols are required for the study of their involvement in the assembly of the 
ATP synthase. 
Materials and Methods  
Human genes ATP5PD and ATP5PF in HAP1 cells and ATP5F1D in HEK293 Flp-InTM T-
RExTM cells were disrupted by CRISPR-Cas9 (32), leading to clonal cells HAP1-Δd, -ΔF6, and 
HEK293-Δδ respectively. HAP1-WT and a clonal HAP1-Δδ cell were purchased from Horizon 
Discovery, Cambridge, U. K. The derivation of HAP1-∆b, -∆e, -∆f and ∆g cells has been 
described before (5, 19). Plasmid pcDNA5TM/FRT/TO encoding either subunit b or j, each with 
tandem C-terminal Strep II and FLAG tags was co-transfected with plasmid pOG44 in the 
presence of Lipofectamine 2000 (Invitrogen) into HEK293-Δδ cells, and stably transformed 
cells expressing the tagged subunits were selected. Cell proliferation was monitored with an 
Incucyte HD instrument (Essen Bioscience), and the oxygen consumption of cells was 
measured in a Seahorse XFe24 analyzer (Agilent Technologies). The oligomeric state of ATP 
synthase and vestigial complexes was examined by BN- and CN-PAGE and Western blotting. 
ATP synthase and vestigial complexes were immuno-purified from mitoplasts, analyzed by 
SDS-PAGE with Coomassie blue staining, and by quantitative mass spectrometry of trypsin 
and chymotrypsin digests. For quantitative MS analyses, proteins were subject to stable isotope 
labelling in cell culture (SILAC). For details, see SI Appendix. 
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Fig. 1. Organization of peripheral stalk and associated subunits in a monomer in dimeric 
ATP synthase in bovine mitochondria. The enzyme is inhibited by residues 1-60 of the 
inhibitor protein IF1, which is bound to the catalytic domain and not defined in the Figure (4). 
Black horizontal lines represent the inner mitochondrial membrane (IMM) separating the 
matrix from the intermembrane space (IMS). The PS is formed from subunits OSCP, F6, d, 
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ATP8 (designated “8”) and b. Subunit b has two transmembrane α-helices, residues 33-47 of 
bH2 and residues 55-73 of bH3, with an angle of 45o between them. The N-terminal 
amphipathic α-helix, bH1 (residues 19-29), lies in the lipid head group region on the matrix 
side of the membrane. These three α-helices form the scaffold for a wedge structure in the 
membrane domain to which subunits e, f, g, j and ATP8, all with single transmembrane α-
helices, are associated. Voids between proteins in the wedge are filled with five specifically 
bound lipids, three cardiolipins and two other lipids, tentatively modelled as 
phosphatidylglycerols (4). The positions of one cardiolipin (defined as CDL1), and the two 
phosphatidyl glycerols (defined as LHG4 and LHG5) are indicated by i-iii, respectively. The 
wedge braces ATP6 against the c8-ring and in the dimer the two interacting wedges hold the 
rotatory axes of the monomeric enzymes at a range of acute angles via pivoting about the j-
subunits in the surfaces of the two wedges (4). Subunit j is involved in the monomer-monomer 
interface in yeast mitochondria (13), but the interactions are different than in the bovine 
structure (4). Subunits e and g make a separate domain not in contact with ATP6 (designated 
“6”) and subunit j, that may promote inner membrane curvature (33–35). Subunit k may be 
involved in tethering dimers together (5). The mitochondrial pmf drives the rotation of the c8-
ring and the attached central stalk (subunits γ, δ and e) by the translocation of protons through 
the interface between the c8 ring and ATP6. The rotation of the central stalk carries energy into 
the catalytic sites of the three β-subunits in the F1-domain (subunit composition α3β3γδe). 
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Fig. 2. Vestigial ATP synthase complexes in HAP1 cells devoid of peripheral stalk 
subunits d and F6. Subunit compositions of vestigial human ATP synthase complexes in 
HAP1-∆d and HAP1-∆F6 cells. The vestigial complexes were immuno-purified from digitonin 
extracts of mitoplasts, fractioned by SDS-PAGE, and proteins were detected with Coomassie 




Fig. 3. Impact of removal of either subunit F6 or d on the composition of vestigial ATP 
synthase complexes. Relative abundances of subunits and the inhibitor protein IF1 in HAP1-
ΔF6 or HAP1-Δd cells, respectively, (A and B) in immunopurified vestigial complexes of ATP 
synthase, or (C and D) in digitonin solubilized mitoplasts. IF1-M1 and -M3 are specific mature 
forms of IF1(5), and f-1 and f-2 are isoforms of subunit f (Swiss-Prot P56134). The digitonin 
extracts of mitoplasts were prepared from 1:1 mixtures of differentially SILAC-labeled HAP1-
WT cells plus either HAP1-ΔF6 or HAP1-Δd cells, and complexes were purified from these 
samples. The purified samples were digested separately, in-solution, with trypsin or 
chymotrypsin, and mitoplast samples were separated by SDS-PAGE and digested in-gel with 
trypsin. Peptide mixtures were fractionated by reverse phase HPLC and analyzed by mass 
spectrometry. The histograms are the median values of both relative abundance ratios 
determined for proteins found in the complementary SILAC experiments. The protein ratio is 
derived from a minimum of two peptide ratios from each experiment, except for ATP6 (B and 
D), control heavy isotope experiments), f-2 (D, both experiments), and IF1-M1 (D, control light 
isotope experiment), where all values are from a single peptide ratio. In mitoplast samples, no 
ratios were obtained for subunit-c or IF1-M3 (C and D). The data for the identified proteins are 




Fig. 4. Oligomeric states of ATP synthase and vestigial complexes in HAP1 cells. 
Mitochondrial membranes from HAP1-WT, -ΔF6 and -Δd cells were extracted with digitonin 
(6 g/g protein). (A and B), Fractionation of extracts by BN-PAGE and CN-PAGE, respectively. 
Complexes were revealed by Western blotting with antibodies against various subunits of ATP 
synthase (indicated below the panels). The positions of complexes are shown on the left: o, 
oligomers; d, dimers; m, monomers; s1, F1-c8 subcomplex; s2, subcomplexes containing 
subunits b, e, f and g. The positions of molecular weight markers are shown on the right. (C), 
assessment of sample loading by Western blotting of digitonin extracts, fractionated by SDS-





Fig. 5. Oligomeric states of ATP synthase and vestigial forms in HAP1-WT, -∆b, -∆e, -∆g, 
-∆f and -∆δ cells. ATP synthase and vestigial complexes were extracted from mitoplasts with 
digitonin (12 g/g protein). Extracts were fractioned by CN-PAGE and complexes detected with 
antibodies against individual subunits of ATP synthase. (A), subunit b. (B), subunit e. The 
lower band in the ∆δ lane is probably free subunit e. (C), subunit g. (D), subunit f. The SDHA 
subunit of complex II and TIM23 are loading controls. On the left, d, and m, dimeric and 
monomeric ATP synthase, respectively; s, subcomplex b-e-g-f in Δδ samples, and b-e-g in 
HAP1-∆f samples. The positions of protein markers are shown on the right. 
 
Fig. 6. Proteins associated with subunits b and j in HEK293T-Δδ cells. Quantitative mass 
spectrometry of affinity purified Flag-Strep II tagged subunit b (bT) and subunit j (jT), and 
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associated proteins. SILAC-labeled HEK293T-Δδ Flp-InTM T-RExTM cells individually 
overexpressing the tagged proteins were grown separately, combined and mitoplast samples 
prepared by a mild digitonin treatment. Proteins in mitoplast samples were extracted using 
digitonin at a higher detergent:protein ratio of 12:1 (g/g), and tagged plus associated proteins 
were purified by Strep II affinity chromatography. The experiment was performed twice, with 
reciprocal SILAC labeling orientations. ■, tagged proteins. ●, ATP synthase subunits. ●, Other 
proteins.  Each data point corresponds to the abundance ratio of an identified protein from the 
two complementary experiments. The data for all of the identified proteins are given in SI 
Appendix, Datasets S9-S11. 
 
	
Fig. 7. Pathway(s) of assembly of the PS of human ATP synthase. (A and B) a tertiary b-e-
g complex observed in HAP1-Δf cells binds subunit f to form the complex observed in HAP1-
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Δδ cells; (C) in the presence of the OSCP and F6, the b-e-g-f subcomplex binds to the F1-c8, 
complex to form the partially stable F1-c8-OSCP-F6-b-e-g-f subcomplex observed in HAP1-Δd 
cells. (D) the stable key intermediate vestigial complex observed in ρ0 cells is formed by the 
addition of the d-subunit; (E and F), two additional pathways of arriving at intermediate (D); 
in (E), a partly stable vestigial complex observed in HAP1-Δe and -Δg cells is elaborated by 
the addition of subunits e and g to form complex (F) observed in HAP1-Δf cells; alternatively 
in (G) key intermediate (D) is formed from (G) observed in HAP1-Δc cells of the independently 
assembled c8-ring. Black horizontal lines represent the inner mitochondrial membrane (IMM) 
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Materials and Methods  
Gene Disruptions. ATP5PD and ATP5PF encoding the d and F6 subunits were disrupted 
individually in human HAP1-WT cells by CRISPR-Cas9 technology (1). Their structures are 
shown in SI Appendix, Fig. S2. HAP1 cells have a haploid karyotype, except for the presence 
of a fragment of chromosome 15 in chromosome 19 and a reciprocal translocation between 
chromosomes 9 and 22 (2, 3). None of these features affects the genes in question, as ATP5PD 
and ATP5PF are on chromosomes 17 and 21, respectively. For ATP5PD a pair of gRNAs 
characteristic of exon II and intron B were selected, and for ATP5PF the gRNA pair were both 
targeted to exon II (SI Appendix, Table S1). Each pair was introduced independently into 
HAP1-WT cells, and screening of clones from single cells for the absence of subunit d or F6 
led to the identification of HAP1-Δd, and -ΔF6 cells. The changes introduced into ATP5PD and 
ATP5PF were sequenced with specific primers (SI Appendix, Table S2), showing that deletions 
had been introduced of 121 and 93 bp, respectively (SI Appendix, Fig. S3). Each deletion had 
arisen from two gRNAs and was mediated by non-homologous end-joining of the deleted 
genomic DNA. The deletion in ATP5PD left only the translational start codon in exon II, and 
also removed two bases of intron B, resulting in the termination of translation after 6 amino 
acids. An in-frame deletion in exon II of ATP5PF removed codons for amino acids 13-43, 
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encompassing 20 residues of the mitochondrial targeting sequence and 11 amino acids at the 
N-terminus of the mature protein sequence. There was no evidence of the targeted protein in 
mitoplast samples from these cells (SI Appendix, Fig. S4). The HAP1-Δδ cells were purchased 
from Horizon Discovery (Cambridge, U. K.) who had used the single gRNA 
GCTGGTCGTGGTGCATGCA to disrupt the gene. The targeted region of the ATP5F1D gene 
was amplified by PCR with the forward and reverse primers 5’-
GTGCCTCACATCAGCGCCAGGTC-3’ and 5’-AGCAGGGTCCCCTCTGGTTCGC-3’, 
respectively. This G-C rich region was sequenced by dGTP chemistry (Source Bioscience) 
showing that the mutation had been introduced into the same location as described previously 
in a HAP1-Δ(c+δ) cell line (4). The production and characterization of HAP1-∆b, -∆e, -∆f, and 
-∆g cells have been described previously (5, 6). 
 Human ATP5F1D, encoding the δ-subunit of ATP synthase was disrupted in a 
HEK293 Flp-InTM T-RExTM cell by CRISPR-Cas9 with the same gRNA used for HAP1 cells. 
The targeted region was amplified by PCR with the same primers that were used in HAP1 cells. 
The two resulting fragments observed by agarose gel electrophoresis were gel purified 
(QIAquick gel extraction kit, Qiagen), cloned into the pCR4-TOPO vector (Thermo Scientific), 
and sequenced with M13 forward and reverse primers, and the dGTP chemistry method 
(Source Bioscience). The HEK293-Δδ clonal cell is unable to produce a functional δ-subunit 
(Fig. S9 and S10). An aberrant 17-18 kDa protein of unknown sequence observed in SDS 
lysates of cells and mitoplasts of HEK293-Δδ cells cross-reacted with an anti-δ antibody, but 
it was unable to promote assembly of intact ATP synthase, as shown by native gel analysis 
(Fig. S9). 
Cell Culture. HAP1-WT (Horizon Discovery) and clonal cells were cultured in Iscove’s 
modified Dulbecco’s medium under standard conditions (7). Cell proliferation was monitored 
with an Incucyte HD instrument (Essen Bioscience) and oxygen consumption rate (OCR) was 
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measured in a Seahorse XFe24 analyzer (Agilent Technologies), as described before (7). OCR 
was normalized to cell number by the sulforhodamine B assay (8). Stable isotope labelling of 
proteins with amino acids in cell culture (SILAC) (9) of HAP1-WT and gene disrupted clonal 
cells was carried out as described before (7). 
Expression and Affinity Purification of Tagged ATP Synthase Subunits. Plasmid 
pcDNA5TM/FRT/TO encoding subunit b or j, with tandem C-terminal Strep II and FLAG tags 
(10) was co-transfected in the presence of Lipofectamine 2000 (Invitrogen) with plasmid 
pOG44 into human HEK293-Δδ Flp-InTMT-RExTM cells (total DNA, 1 μg; 
pOG44:pcDNA5/FRT/TO, 7:1 by weight). After 24 h, the medium was replaced with the 
selective medium containing blasticidin (10 μg/ml) and hygromycin (100 μg/ml) and inducible 
cell clones expressing the recombinant protein were picked and verified by Western blotting 
of cell lysates with an anti-Strep II antibody. SILAC-labelling of cell proteins in culture was 
performed as described before (11), and expression of tagged subunits was induced for 72 h 
with doxycycline (20 ng/ml) prior to harvesting the cells. The SILAC DMEM media was also 
supplemented with 20 mM HEPES (pH 7.4) to aid buffering of the increased acidification of 
the media by these cell clones. Reciprocally labelled HEK293T-Δδ-bT (tagged subunit-b) and 
HEK293T-Δδ-jT (tagged j subunit) were mixed 1:1 (protein w/w). Mitoplast material was 
prepared by digitonin treatment (11, 12) and then solubilized with digitonin (12 g/g protein) 
for affinity purification of tagged subunits and associated proteins. A sample was loaded at 4oC 
onto a Pierce spin column (0.9 ml; Thermo Fisher Scientific) containing Strep-Tactin-
Sepharose (IBA Lifesciences) and then washed with 5 column volumes of buffer [20 mM 
HEPES, pH 7.6, 150 mM NaCl, 2 mM dithiothreitol, 1x cOmplete EDTA-free protease 
inhibitor (Roche), and 0.05% (w/v) digitonin]. Bound protein was eluted with 6 portions of 0.5 
column volumes of buffer containing 10 mM desthiobiotin. Eluates were analyzed by SDS-
PAGE and quantitative mass spectrometry. A distinction was made between the endogenous 
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subunits and the tagged form by the different migration positions on the SDS-PAGE gel. From 
the MaxQuant evidence file for the appropriate gel sections, the protein ratios of the tagged 
and endogenous subunits were determined manually (SI appendix, Datasets S10 and S11). 
General Methods. Cell protein concentrations were determined by either the bicinchoninic 
acid assay (Thermo Fisher Scientific) or the detergent compatible protein assay (BioRad). 
Mitoplasts were prepared from cells with digitonin, as described before (11, 12). Extracts of 
mitoplasts made with dodecylmaltoside (DDM; 1%, w/v) were fractionated by SDS-PAGE, 
and subunits of ATP synthase and citrate synthase were detected by Western blotting. The 
oligomeric states of ATP synthase and vestigial complexes in digitonin extracts of mitoplasts 
were examined by BN-PAGE or CN-PAGE (13, 14), and Western blotting. Samples of 
mitoplasts were re-suspended to ca. 5 mg/ml in NativePAGE sample buffer (Thermo Fisher 
Scientific) containing digitonin (6-12 g/g protein), kept at 4°C for 15 min, and then centrifuged 
(10,500 x g, 20 min, 4°C). The supernatants were treated with benzonase (Merck Millipore) at 
room temperature, centrifuged again, and soluble complexes fractionated at 4°C in 3-12% 
acrylamide gradient Bis-Tris gels (Thermo Fisher Scientific) by CN-PAGE, or BN-PAGE 
according to the manufacturer’s instructions for Western blotting. For CN-PAGE the cathode 
running buffer contained 0.05% (w/v) sodium deoxycholate plus 0.005% (w/v) DDM. The gel 
resolved complexes were transferred to polyvinylidene fluoride membranes, and the 
membranes were probed with subunit specific antibodies. The origins of the antibodies either 
have been described before (5, 6), or they are listed in SI Appendix Table S3. ATP synthase 
was purified from digitonin solubilized mitoplasts with an immuno-capture resin (Abcam) as 
described before (7). Proteins in SILAC labelled mitoplast samples for quantitative mass 
spectrometric analysis were reduced and alkylated in gel sample buffer, fractionated by SDS-
PAGE and stained with Coomassie blue R250 dye (15). Stained gel sections were excised and 
proteins digested in-gel with trypsin (16). SILAC labelled and affinity purified samples of ATP 
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synthase were ethanol precipitated at -20ºC for 18 h with 20 vol. cold ethanol, centrifuged, and 
the pellet was digested in 50 mM ammonium bicarbonate for 18 h, with either trypsin at 37ºC 
or chymotrypsin at 30ºC. 
Protein Quantitation. Relative quantitation of proteins was derived from mass spectrometric 
data of SILAC samples (9). Peptide mixtures was analyzed by LC-MS-MS on a Proxeon 
EASY-nLC1000 system coupled directly to a Q-Exactive+ Orbitrap mass spectrometer 
(Thermo Fisher Scientific). Heavy and light peptide mass data were analyzed with MaxQuant 
version 1.6.5.0, and the integrated Andromeda search engine (17, 18) employing a Swiss-Prot 
human protein database (March 2019) modified to include mature forms of ATP5IF1, denoted 
as IF1-M1, -M2 and -M3, with N-terminal residues Phe-25, Gly-26 and Ser-27, respectively 
(19, 20), and a mature ATP synthase c-subunit. The ATP synthase c-subunit is encoded by 
three genes (21, 22), with different mitochondrial targeting pre-sequences, but identical mature 
protein sequences. To aid identification of this subunit, using peptides derived from the mature 
protein N-terminal sequence, a representative sequence (lacking the mitochondrial N-terminal 
import sequence) was added to the human protein database employed in these analyses, with 
the identifier P48201-M. In addition, lysine trimethylation was included when interrogating 
chymotrypsin digest data, to aid identification of a characteristic methylated subunit-c peptide 
(23). Search parameters for in-gel trypsin digest samples were: MS tolerance 4.5 p.p.m.; 
MS/MS tolerance 20 p.p.m.; Trypsin/P with two missed cleavages; Fixed modification - Cys-
carbamidomethyl; variable modifications - oxidation (Met) and acetyl (protein N-terminus); 
Arg-10 and Lys-8. In solution digest sample parameters were: MS tolerance 4.5 p.p.m.; MS/MS 
tolerance 20 p.p.m.; trypsin/P with two missed cleavages; chymotrypsin with four missed 
cleavages; variable modifications - oxidation (Met), acetyl (protein N-term) and trimethyl 
(lysine); Arg-10 and Lys-8. The MaxQuant output was managed further with Perseus (24). 
Protein ratios for ATP5IF1 were calculated manually with data for the unique N-terminal 
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peptides of the various mature forms of ATP5IF1, located in the MaxQuant evidence file, and 
represent the median of the assigned specific peptide ratios, where MaxQuant ISO-MSMS 
peptide values were used only if fewer than three MULTI-MSMS peptide ratios were obtained. 
The basis of quantitative experiments using SILAC has been described previously (25). 
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Fig. S1. Structure of wedge components in the membrane domain of bovine ATP synthase 
and possible points and order of incorporation of lipids into the wedge in the human 
enzyme. See (26). A, the membrane domain of subunit b, viewed orthogonal to the plane of 
the IMM, consisting of amphipathic α-helix bH1 (residues 19-29) in the head-group region on 
the matrix side of the IMM, transmembrane α-helix bH2 (residues 33-47) and the membrane 
region (residues 55-73) of bH3. In B, according to the assembly pathways in Fig. 7, subunits e 
and g associate with b to form the b-e-g intermediate. In C, subunit f is incorporated 
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subsequently to complete the protein components of the wedge; D-H, possible points of 
incorporation of lipids. In E-G, CDL3, LGH4 and LGH5 could be incorporated before or after 
the addition of e and g to b to form b-e-g, but before incorporation of f. In H, CD1 is 
incorporated after the formation of the b-e-g intermediate to complete the b-e-g-f complex.  
 
 
Fig. S2. Structures of the human genes ATP5PD and ATP5PF encoding subunits d and 
F6, respectively, of ATP synthase. Exons are labelled with Roman numerals. Black and 
unfilled boxes in exons represent, respectively, protein coding and non-coding regions. Introns 
labelled with capital letters are depicted as intervening continuous lines. The sizes of introns 
and coding regions of exons are given in base pairs (bp). The scale bars on the right represent 
500 bp. The exon-intron information was obtained from http://www.ensembl.org. The 
structures of ATP5PD and ATP5PF correspond to transcript ID reference 
ENST00000301587.9 and ENST00000400087.7. Images were drawn with the Exon-Intron 







Table S1. Target sites for gRNAs employed in the disruption of human genes ATP5PD 






*Antisense sequence used for gRNA 
 
Table S2. Primers employed in the amplification by PCR of regions targeted by gRNAs 









Fig. S3. Sequences of genes ATP5PD and ATP5PF disrupted by CRISPR-Cas9, and the 
encoded protein sequences in clonal HAP1-∆d and -∆F6 cells. The sequences are compared 
to the corresponding wild-type (WT) sequences. (A) ATP5PD and d subunit and (B) ATP5PF 
and F6 subunit. Carets indicate the PAM (protospacer adjacent motif) sequences for each guide 
RNA, and solid lines for the target sequences for guide RNAs. The WT sequences are parts of 
intron A (grey box), all of exon II and part of intron B (grey box), aligned with the 
corresponding deleted sequences. The arrows indicate the start codons in exon II. The deleted 
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regions are denoted by dashed lines, and asterisks indicate non-matched amino acid to the wild-
type. 
 
Fig. S4. Deletion of subunits d and F6 from the peripheral stalk region of human ATP 
synthase in HAP1 cells. Mitoplasts from HAP1-WT, -∆d and -∆F6 clonal cells were extracted 
with n-dodecyl-β-D-maltoside. The extracts were fractionated by SDS-PAGE. Then the 
proteins were transferred to membranes and probed with antibodies against subunits indicated 
on the left. Citrate synthase (CS) was employed as a loading control. 
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Fig. S5. Characteristics of HAP1-Δd cells and HAP1-ΔF6 cells. (A and B), growth rates; (C 
and D) cellular oxygen consumption rates (OCR); (E and F) extracellular acidification rates 
(ECAR), of HAP1-WT cells (●) and HAP1 cells with disrupted genes for subunit d (■), or 
subunit F6 (■). Growth rates were measured by seeding 105 cells into each well of a 6-well 
plate, and by monitoring their confluence over time. Initial confluences were adjusted to similar 
levels for comparison. The data points are the mean values ± SD (n = 3 wells). OCR and ECAR 
were measured with a Seahorse XFe24 instrument, before and after sequential additions of 
oligomycin (Oligo), carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), and a 
mixture of rotenone and antimycin A (Rot/AA). Data represent the mean ± SEM (n=10 wells). 
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Fig. S6. Effect of deletion of subunits F6 and d on the assembly of human electron transfer 
complexes. Mitochondrial membranes from HAP1-WT, -ΔF6 and -Δd cells were extracted 
with digitonin (9 g/g protein), and the extracts were fractionated by BN-PAGE. Complexes 
were detected by western blotting with antibodies against complexes I (NDUFS2), III 
(UQCRC1) and IV (COX4). Complex II (CII-SDHA) provided a loading control. CI, complex 
I; CIII2, complex III dimer; CIV, complex IV; CIV2, complex IV dimer; CIII2+CIV, complex 
III dimer plus complex IV; SC, supercomplex; sub, subcomplexes. The migration positions of 
standard proteins are shown on the right. 
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Fig. S7. Relative protein abundances in ATP synthase complexes purified from HAP1-
ΔF6 and HAP1-Δd cells. (A) and (B), respectively, immunocaptured ATP synthase from 
HAP1-ΔF6 and HAP1-Δd cells. Samples were prepared from a 1:1 mixture of HAP1-WT cells 
with either HAP1-ΔF6 cells or HAP1-Δd cells, that were differentially SILAC-labelled. The 
experiments were performed twice with reciprocal SILAC labelling orientations. The protein 
ratio is derived from a minimum of two peptide ratios from each experiment, except for ATP6 
from HAP1-Δd in experiment 2, where the value is from a single peptide ratio. The ratios for 
proteins obtained in both experiments are plotted as a single point on a scatter plot as the log 
base 2 value. ●, ATP synthase subunits and forms of IF1; ●, assembly factors ATPAF2, FMC1 
and TMEM70; ●, all other proteins. In (B), the data point for Rab11 family-interacting protein 
3, RAB11FIP3 (-5.40, 4.59) is outside the axes, in the upper left ‘contaminant’ quadrant. 
Protein ratios are given in SI Appendix Datasets S1-S4. 
 
 
Fig. S8. Effects on protein relative abundance in mitoplast samples of HAP1 cells of the 
individual deletion of the d-subunit or F6-subunit of human ATP synthase. Samples were 
prepared from a 1:1 mixture of HAP1-Δd or HAP1-ΔF6 cells with HAP1-WT cells that were 
differentially SILAC-labelled. The experiments were performed twice, using reciprocal SILAC 
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labelling orientations. (A and B), the ratios for all proteins determined in both of the 
experimental labelling orientations are plotted as a single point on a scatter plot, as the log base 
2 value, for mitoplast samples from HAP1-Δd and HAP1-ΔF6 cells, respectively. The protein 
ratio is the median value derived from a minimum of two peptide ratios from each experiment, 
except for ATP synthase subunit ATP6 in the HAP1-Δd experiment 2, subunit f-2 in both 
HAP1-Δd experiments, and IF1-M1 in the HAP1-Δd experiment 1, which only gave one 
peptide ratio. ●, ATP synthase subunits and the M1 mature forms of IF1; ●, assembly factors 
ATPAF1, ATPAF2, and TMEM70; ●, all other identified proteins. Protein ratios are listed in 
Datasets S5-S8.  
 
Fig. S9. Vestigial complexes of ATP synthase in HEK293-Δδ cells. (A) Fractionation of 
digitonin extracted complexes from mitoplasts of WT and HEK293-Δδ cells. Samples were 
extracted with digitonin (6 or 10 g/g protein) and the extracted complexes were fractionated by 
CN-PAGE, followed by Western blotting and probed with antibodies against subunits b, e, g, 
f and β (as indicated above the panels). The positions of complexes are shown on the left: d, 
ATP synthase dimer; m, ATP synthase monomer; s1, subcomplexes containing subunits b, e, f 
and g. (B) SDS extracted proteins from wild-type (WT) and HEK293-Δδ cells were 
fractionated by SDS-PAGE and β-, γ- and δ-subunits were detected by western blotting. The 
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HEK293-∆δ cells have a weak band detected with an anti-δ antibody at ca. 17-18 kDa, marked 
with an asterisk.  
 
 
Fig. S10. Disruption of the gene for the δ-subunit of human ATP synthase in HEK293 
Flp-InTM T-RExTM cells by CRISPR-Cas9. Clonal cells were derived with two differently 
edited versions of ATP5F1D, with in (A), a 20 bp deletion, and in (B), a 1140 bp insertion 
(sequence not shown) at the position indicated by the arrowhead. In the upper sections of (A) 
and (B), the disrupted DNA sequences are aligned with the wild-type (WT) sequence. The 
carets above the DNA sequences indicate the PAM (protospacer adjacent motif) sequence for 
the guide RNA, and solid lines the guide RNA target sequence. In the lower sections, the impact 
 43 
of the deletions on the protein sequence of the δ-subunit are shown. Asterisks indicate changes 
in the protein sequence arising from the deletions, and the dashes indicate that the protein 
sequence has been terminated by the introduction of a stop codon. In (A) and (B), respectively, 
truncated versions of the δ-subunit were produced consisting of residues 1-88 followed by 50 
and 13 unmatched residues. By internal initiation of the translation from four cryptic AUG 
codons, it is possible that the insertion might lead also to the production of residues 124-168 
of the δ-subunit and three unrelated polypeptides (90, 62 and 117 amino acids long, not shown). 
 
Table S3. Sources of Antibodies 
Protein Source Antibody 
ATP synthase δ Proteintech 14893-1-AP  
 ABclonal A9929 
ATP synthase b Abcam ab217062  
ATP synthase c Abcam ab180149, ab181243 
ATP synthase F6 Abcam ab224139 
ATP synthase OSCP Proteintech 66696-1-Ig 
ATP synthase d Proteintech 
In-house 
17589-1-AP 
Rabbit polyclonal against 
recombinant bovine protein 
ATP synthase ATP8 Proteintech 26723-1-AP 
PHB2 Proteintech 12295-1-AP 
SDHB Sigma HPA002868 
Strep II Abcam ab184224 
TIM23 Abcam ab230253 
 
